Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, …
Over the last 12 months, insiders at Envista Holdings Corporation have bought $1.32M and sold $0 worth of Envista Holdings Corporation stock.
On average, over the past 5 years, insiders at Envista Holdings Corporation have bought $661,893 and sold $18.04M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Keel Paul A (Chief Executive Officer) — $1.01M. Hammes Eric D. (Chief Financial Officer) — $801,215. Aghdaei Amir (Chief Executive Officer) — $215,253.
The last purchase of 30,000 shares for transaction amount of $506,100 was made by Keel Paul A (Chief Executive Officer) on 2024‑08‑13.
2024-08-13 | Chief Executive Officer | 30,000 0.0181% | $16.87 | $506,100 | 0.00% | |||
2024-08-12 | Chief Financial Officer | 24,532 0.0144% | $16.33 | $400,608 | +14.03% | |||
2023-11-16 | SVP, Orthodontics | 2,185 0.0013% | $22.89 | $50,015 | -12.90% | |||
2023-11-08 | General Counsel | 5,000 0.0029% | $21.75 | $108,750 | -6.80% | |||
2023-11-06 | Chief Executive Officer | 10,000 0.0059% | $21.53 | $215,253 | -5.35% | |||
2023-11-06 | Principal Financial Officer | 2,000 0.0012% | $21.53 | $43,060 | -5.35% | |||
2023-02-28 | Sale | Chief Financial Officer | 10,016 0.006% | $37.90 | $379,606 | -17.47% | ||
2022-11-17 | Sale | Chief Financial Officer | 657 0.0004% | $36.55 | $24,013 | -6.69% | ||
2022-04-18 | Sale | Chief Financial Officer | 5,341 0.0033% | $45.73 | $244,244 | -16.99% | ||
2022-03-29 | Sale | Chief Executive Officer | 3,801 0.0025% | $51.50 | $195,752 | -22.61% | ||
2022-03-18 | Sale | Chief Executive Officer | 6,737 0.0041% | $49.75 | $335,166 | -23.85% | ||
2022-03-18 | Sale | Chief Financial Officer | 4,786 0.003% | $50.86 | $243,416 | -23.85% | ||
2022-03-18 | Sale | SVP, Strategy & Bus. Dev. | 10,092 0.0062% | $50.00 | $504,600 | -23.85% | ||
2022-03-16 | Sale | Chief Executive Officer | 8,982 0.0055% | $47.75 | $428,891 | -20.24% | ||
2022-03-01 | Sale | Chief Human Resources Officer | 4,181 0.0026% | $47.83 | $199,977 | -19.50% | ||
2022-03-01 | Sale | SVP, Strategy & Bus. Dev. | 2,958 0.0018% | $47.83 | $141,481 | -19.50% | ||
2022-02-25 | Sale | Chief Financial Officer | 7,196 0.0044% | $47.81 | $344,041 | -20.93% | ||
2022-02-25 | Sale | Chief Human Resources Officer | 16,892 0.0102% | $47.71 | $805,917 | -20.93% | ||
2022-02-25 | Sale | SVP, Strategy & Bus. Dev. | 18,574 0.0112% | $47.65 | $884,963 | -20.93% | ||
2022-02-11 | Sale | SVP, Strategy & Bus. Dev. | 12,112 0.0076% | $47.50 | $575,320 | -17.65% |
Keel Paul A | Chief Executive Officer | 402605 0.2339% | $21.78 | 1 | 0 | |
Aghdaei Amir | Chief Executive Officer | 295362 0.1716% | $21.78 | 2 | 12 | <0.0001% |
Conley Eric | SVP, Orthodontics | 47376 0.0275% | $21.78 | 1 | 0 | |
Nance Mark E | General Counsel | 39042 0.0227% | $21.78 | 1 | 5 | |
Hammes Eric D. | Chief Financial Officer | 24532 0.0143% | $21.78 | 1 | 0 |
BlackRock | $442.78M | 12.05 | 20.71M | +13.3% | +$51.98M | 0.01 | |
The Vanguard Group | $366.44M | 9.97 | 17.14M | -0.17% | -$609,158.96 | 0.01 | |
Morgan Stanley | $361.43M | 9.84 | 16.91M | +3.81% | +$13.26M | 0.03 | |
Harris Associates | $208.66M | 5.68 | 9.76M | -10.07% | -$23.36M | 0.34 | |
Ariel Investments | $190.12M | 5.17 | 8.89M | +25.3% | +$38.38M | 1.87 |